Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a heart condition called obstructive hypertrophic cardiomyopathy (a thickening of the heart muscle that blocks blood flow) and your doctor has started you on a medication called Mavacamten for this condition at a medical facility in Japan during the study enrollment period.
Who may not be able to join:
- You are taking Mavacamten for any reason other than its officially approved use (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bristol Myers Squibb, Bristol-Myers Squibb
Phone: 855-907-3286
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of adverse events (AEs) and/or serious AEs (SAEs); Actions taken after adverse events (AEs) and/or serious AEs (SAEs); Outcome of adverse events (AEs) and/or serious AEs (SAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.